Director Debra Mallonee Hart of Great Southern Bancorp, Inc. filed a Form 4 on November 19, 2026, disclosing a voluntary DRIP acquisition of common stock on October 14, 2026, and the grant of options to purchase common stock on November 18, 2026, as reported to the SEC.
Key Highlights
- DRIP acquisition: Hart acquired 11 shares of common stock on October 14, 2026, at a price of $77.1139 per share, reported voluntarily as a DRIP acquisition exempt from Section 16 reporting.
- Post-DRIP ownership: Following that transaction, Hart directly held 2,035 shares of common stock.
- New options granted: Four tranches of options to purchase common stock were granted on November 18, 2026, each covering 500 shares at an exercise price of $79.17, with varying exercise dates from November 18, 2028, through November 18, 2031, all expiring November 18, 2036.
- Total new options: The four new tranches bring Hart's cumulative options to purchase common stock to 2,000 shares from this grant, with running totals reported as 500, 1,000, 1,500, and 2,000 respectively after each tranche.
- Total derivative holdings: Following all reported transactions, Hart holds options to purchase a cumulative total of 25,000 shares of common stock across all outstanding option grants, all held directly.
- Filing signed by attorney: The form was signed by Matt Snyder under a Power of Attorney from Debra Mallonee Hart, dated November 19, 2026.
Hart's October DRIP Purchase and November Option Grant at Great Southern Bancorp
According to the filing, Debra Mallonee Hart, identified as a director of Great Southern Bancorp, Inc. (NASDAQ:GSBC), reported two categories of transactions. The first was a voluntary disclosure of a Dividend Reinvestment Plan (DRIP) acquisition of 11 shares of common stock on October 14, 2026, at $77.1139 per share, coded as transaction code "J." The filing notes this acquisition is "exempt from Section 16 reporting being reported voluntarily." After this transaction, Hart's directly held common stock position stood at 2,035 shares.
The second set of transactions involves the grant on November 18, 2026, of four separate options to purchase common stock, each covering 500 shares at an exercise price of $79.17 per share, all expiring November 18, 2036. The tranches become exercisable on November 18, 2028; November 18, 2029; November 18, 2030; and November 18, 2031, respectively. These are all held directly and were coded as acquisitions.
In addition to the newly granted options, the filing discloses Hart's pre-existing portfolio of options to purchase common stock at various exercise prices ranging from $41.74 to $61.79, covering grants with expiration dates extending from March 2027 through November 2035. After accounting for all reported option holdings, the filing shows a total of 25,000 options to purchase common stock beneficially owned directly by Hart following these transactions.
What Was Disclosed
The filing disclosed a voluntary DRIP share acquisition of 11 shares at $77.1139 on October 14, 2026, and four new option tranches totaling 2,000 shares at $79.17 granted November 18, 2026, bringing Hart's total option holdings to 25,000 shares.



Please wait processing your request...